[1]
Topf, J., Wen, W. , Munera, C., Menzaghi, F. and Schömig, M. 2021. Efficacy of Difelikefalin in Subjects With Moderate-to-Severe Chronic Kidney Disease–Associated Pruritus: Pooled Subgroup Analysis of KALM-1 and KALM-2. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s77. DOI:https://doi.org/10.25251/skin.5.supp.77.